论文部分内容阅读
目的将新构建的人肝细胞生长因子质粒VM202转载入梗死后的心肌内,对这种以避免左心室(LV)重构而达到保护目的的治疗方法进行评价。材料和方法此项研究通
OBJECTIVE: The purpose of this study is to evaluate the therapeutic approach of protecting the myocardium by avoiding the remodeling of left ventricle (LV) by introducing the newly constructed human hepatocyte growth factor plasmid VM202 into the myocardium after infarction. Materials and Methods This study was conducted